Related Experiment Videos
Transcriptional profiling and drug discovery
Karen Joy Shaw1, Brian J Morrow
1Johnson & Johnson Pharmaceutical Research & Development, 3210 Merryfield Row, San Diego, CA 92121, USA. kshaw2@prdus.jnj.com
Current Opinion in Pharmacology
|October 16, 2003
Summary
DNA microarrays leverage microbial genome data to combat antimicrobial resistance. This technology aids in understanding drug resistance mechanisms and identifying new drug targets for infectious diseases.
Area of Science:
- Genomics
- Microbiology
- Bioinformatics
Background:
- Antimicrobial drug resistance is a growing global challenge.
- Increasing availability of microbial whole-genome sequence data offers new research avenues.
- Understanding pathogenic microbes is crucial for developing effective treatments.
Purpose of the Study:
- To explore the utility of DNA microarrays in analyzing microbial genomes.
- To characterize antimicrobial resistance mechanisms and drug action.
- To identify novel drug targets and understand host-pathogen interactions.
Main Methods:
- Utilizing whole-genome nucleotide sequence data from microbial species.
- Employing DNA microarrays for genome-wide expression profiling.
- Analyzing host and pathogen responses during infection.
Main Results:
- DNA microarrays enable a global perspective on pathogenic microbial genomes.
- Genome-wide expression profiles help elucidate mechanisms of antimicrobial action and resistance.
- Characterization of genes with unknown functions can lead to new drug target identification.
Conclusions:
- DNA microarrays are powerful tools for studying antimicrobial resistance.
- This approach enhances understanding of pathogenesis and strategies against infectious diseases.
- Genomic data combined with microarray technology facilitates the discovery of novel therapeutic strategies.